C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
1.67 AUD
-1.76%
Market Closed
Updated:
May 15, 2024
Cyclopharm Ltd
Selling, General & Administrative
|
Cyclopharm Ltd
Selling, General & Administrative Peer Comparison
Comparables:
NTI
IPD
COH
OIL
EMV
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Selling, General & Administrative
-AU$21.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-10%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Selling, General & Administrative
-AU$1.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Selling, General & Administrative
-AU$29.3m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-12%
|
|
|
Cochlear Ltd
ASX:COH
|
Selling, General & Administrative
-AU$873.5m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-13%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Selling, General & Administrative
-AU$5.1m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-17%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Selling, General & Administrative
-AU$8.6m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-86%
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Selling, General & Administrative?
Selling, General & Administrative
-21.1m
AUD
-21.1m
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Selling, General & Administrative amounts to -21.1m AUD.
What is Cyclopharm Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-10%
-10%
Over the last year, the Selling, General & Administrative growth was -13%. The average annual Selling, General & Administrative growth rates for Cyclopharm Ltd have been -14% over the past three years , -18% over the past five years , and -10% over the past ten years .
You don't have any saved screeners yet
